In ₹ Crore except Per Share 12 Months Ending | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 11.7 | 12.7 | 13.4 | 14.5 | 15.8 | 18.3 | 21.3 | 22.2 | |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Income | 11.7 | 12.7 | 13.4 | 14.5 | 15.8 | 18.3 | 21.3 | 22.2 | |
| Expenses | |||||||||
| + Employee Benefit Expense | 1.7 | 1.8 | 2.0 | 2.1 | 2.3 | 2.3 | 2.4 | 2.4 | |
| + Finance Costs | 4.4 | 4.8 | 5.4 | 6.4 | 6.9 | 8.6 | 9.4 | 10.0 | |
| + Depreciation & Amortisation | 0.3 | 0.3 | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 | |
| + Other Expenses | 0.9 | 0.9 | 1.1 | 1.1 | 1.7 | 1.5 | 1.1 | 1.4 | |
| Total Expenses | 7.3 | 7.9 | 9.2 | 10.4 | 11.7 | 13.1 | 13.9 | 14.5 | |
| EBITDA | 9.0 | 9.8 | 9.9 | 10.8 | 11.5 | 14.2 | 17.3 | 18.2 | |
| EBIT | 8.7 | 9.5 | 9.5 | 10.5 | 11.1 | 13.7 | 16.9 | 17.7 | |
| Profit | |||||||||
| PBT before Exceptional Items | 4.3 | 4.7 | 4.2 | 4.1 | 4.1 | 5.2 | 7.4 | 7.7 | |
| + Exceptional Items | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Pretax Income | 4.3 | 4.7 | 3.8 | 4.1 | 4.1 | 5.2 | 7.4 | 7.7 | |
| + Current Tax | 1.1 | 1.3 | 1.3 | 1.1 | 1.2 | 1.5 | 2.1 | 1.9 | |
| + Deferred Tax | 0.0 | -0.0 | -0.1 | -0.0 | -0.1 | -0.1 | -0.2 | 0.0 | |
| Tax Expense | 1.1 | 1.3 | 1.2 | 1.1 | 1.1 | 1.4 | 1.9 | 2.0 | |
| Net Income | 3.2 | 3.5 | 2.6 | 3.0 | 3.0 | 3.8 | 5.5 | 5.7 | |
| + Net Income — Continuing Ops | 3.2 | 3.5 | 2.6 | 3.0 | 3.0 | 3.8 | 5.5 | 5.7 | |
| + Other Comprehensive Income | 1.0 | 0.0 | 0.4 | -0.0 | 0.1 | -0.0 | 5.4 | -0.0 | |
| Total Comprehensive Income | 4.3 | 3.5 | 3.1 | 3.0 | 3.1 | 3.8 | 10.8 | 5.7 | |
| Per Share | |||||||||
| Basic EPS | 1.65 | 1.78 | 1.34 | 1.53 | 1.48 | 1.82 | 2.59 | 2.70 | |
| Diluted EPS | 1.63 | 1.75 | 1.30 | 1.49 | 1.43 | 1.82 | 2.59 | 2.70 | |
| Revenue Detail — as filed | |||||||||
| + Fees & Commission Income | 0.3 | 0.4 | 0.4 | 0.4 | 0.6 | 0.8 | 1.0 | 0.6 | |
| Expense Detail — as filed | |||||||||
| + Impairment on Financial Instruments | 0.0 | 0.2 | 0.3 | 0.4 | 0.4 | 0.3 | 0.5 | 0.2 | |
| Other Comprehensive Income — detail | |||||||||
| + Other Comprehensive Income | 1.0 | 0.0 | 0.4 | -0.0 | 0.1 | -0.0 | 5.4 | -0.0 | |
| + Items NOT to be Reclassified to P&L | 1.3 | 0.0 | 0.4 | -0.0 | 0.2 | 0.0 | 6.3 | -0.0 | |
| + Tax on Items NOT to be Reclassified | — | — | 0.0 | -0.0 | 0.0 | 0.0 | 0.9 | -0.0 | |
| + Tax on Items NOT to be Reclassified — alt tag | 0.3 | 0.0 | — | — | — | — | — | — | |
| Per Share — as-filed variants | |||||||||
| Basic EPS — Continuing Operations | 1.65 | 1.78 | 1.34 | 1.53 | 1.48 | 1.82 | 2.59 | 2.70 | |
| Diluted EPS — Continuing Operations | 1.63 | 1.75 | 1.30 | 1.49 | 1.43 | 1.82 | 2.59 | 2.70 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||
| Related-party Transactions — During the Period | — | — | 25.3 | — | 77.9 | — | 137.7 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||
| Gross Profit | 11.7 | 12.7 | 13.4 | 14.5 | 15.8 | 18.3 | 21.3 | 22.2 | |
| Gross Margin % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||
| Pretax Income (Adjusted, as filed) | 4.3 | 4.7 | 4.2 | 4.1 | 4.1 | 5.2 | 7.4 | 7.7 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net Income Adj (tax-effected) | 3.2 | 3.5 | 2.8 | 3.0 | 3.0 | 3.8 | 5.5 | 5.7 | |
| EPS Adj | 1.65 | 1.78 | 1.46 | 1.53 | 1.48 | 1.82 | 2.59 | 2.70 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Filed Debt Equity | — | — | 0.01 | 0.02 | 0.02 | — | — | — | |
| Interest Earned | 11.3 | 12.3 | 13.0 | 14.0 | 15.2 | 17.5 | 20.3 | 21.5 | |
| Paid Up Equity Capital | 19.6 | 19,56,398.6 | 19,56,398.6 | 19.6 | 21,11,398.6 | 21.1 | 21.1 | 21.1 | |